Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Not guideline indicated, GLP: no data

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1981

Materials and methods

Test guideline
Qualifier:
no guideline followed
GLP compliance:
not specified
Type of assay:
micronucleus assay

Test material

Constituent 1
Reference substance name:
Ascorbic acid
EC Number:
200-066-2
EC Name:
Ascorbic acid
Cas Number:
50-81-7
IUPAC Name:
5-(1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one (non-preferred name)
Details on test material:
- Name of test material (as cited in study report): Ascorbic Acid

Test animals

Species:
mouse
Strain:
CD-1
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles-River, Paris

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
- Vehicle(s)/solvent(s) used: DMSO
Details on exposure:
The substance was administered i.p. twice, 24 hrs apart.
Duration of treatment / exposure:
2 doses within 24 hours
Frequency of treatment:
24 hours
Post exposure period:
The animals were killed 6 hours after the second application.
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 80, 160, 320 mg/kg bw
Basis:
nominal conc.
No. of animals per sex per dose:
2
Control animals:
yes, concurrent vehicle
Positive control(s):
no data

Examinations

Tissues and cell types examined:
Femoral bone marrow cells
Details of tissue and slide preparation:
DETAILS OF SLIDE PREPARATION:
Smears were prepared according to the method described by Schmid (1973: Agents Actions 3: 77-85) (1975: the micronucleous test. Mutat Res. 31: 9-15). For staining the slides, phosphate buffer 8pH 6.88) was used instead of distilled water. All slides were coded.

METHOD OF ANALYSIS:
Screening of the slides was performed, using 10x16 magnification, for regions where cells were well spread and optimally stained. 1,500 polychromatic erythrocytes per animal were analysed under oil-immersion high power magnification (10x100). The number of micronucleated polychromatic erythrocytes (MPEs) were counted, but not the number of micronuclei.
Evaluation criteria:
1) two or more mice per group with MPE frequencies above 0.40 %
2) one or more tested groups with mean MPE frequencies above 0.30 %
3) statistical significance (Kastenbaum and Bowman, 1970) in one or more treated groups

A test substance was judged positive when all three of these criteria were met, negative when they were not, and questionable when one or two were met.
Statistics:
Statistical significance (Kastenbaum and Bowman, 1970)

Results and discussion

Test results
Sex:
male/female
Genotoxicity:
negative
Toxicity:
not specified
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
not examined
Additional information on results:
Micronucleated polychromatic erythrocytes (%):
Negative control: 0.12 (0.00-0.20)
80 mg/kg bw: 0.15 (0.13-0.20)
160 mg/kg bw: 0.05 (0.00-0.13)
320 mg/kg bw: 0.08 (0.00-0.13)

Applicant's summary and conclusion